Irish Medicines Database — 10,165 HPRA-Authorised Products

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

84 results for “Baxter”

Medicine	Active substance	Licence holder	Status
Propofol 10 mg/ml Emulsion for injection/infusion PA2299/038/001	Propofol	Baxter Holding B.V.	Marketed
Propofol 20 mg/ml Emulsion for injection/infusion PA2299/038/002	Propofol	Baxter Holding B.V.	Marketed
Ringer’s Solution for Infusion, Viaflo container PA2299/011/001	Sodium chloride, Potassium chloride, Calcium chloride dihydrate	Baxter Holding B.V.	Marketed
RIXUBIS 1000 IU powder and solvent for solution for injection EU/1/14/970/003	Nonacog gamma	Baxter Innovations GmbH	—
RIXUBIS 2000 IU powder and solvent for solution for injection EU/1/14/970/004	Nonacog gamma	Baxter Innovations GmbH	—
RIXUBIS 250 IU powder and solvent for solution for injection EU/1/14/970/001	Nonacog gamma	Baxter Innovations GmbH	—
RIXUBIS 3000 IU powder and solvent for solution for injection EU/1/14/970/005	Nonacog gamma	Baxter Innovations GmbH	—
RIXUBIS 500 IU powder and solvent for solution for injection EU/1/14/970/002	Nonacog gamma	Baxter Innovations GmbH	—
Sevoflurane Baxter, 100%, inhalation vapour, liquid PA2299/031/001	Sevoflurane	Baxter Holding B.V.	Marketed
Sodium Chloride 0.18% w/v and Glucose 4.0% w/v Intravenous Infusion BP, (Viaflo Container) PA2299/008/005	Sodium chloride, Anhydrous glucose	Baxter Holding B.V.	Marketed
Sodium Chloride 0.3% w/v and Glucose 3.3% w/v Solution for Infusion BP PA2299/008/004	Sodium chloride, Glucose	Baxter Holding B.V.	Marketed
Sodium Chloride 0.45% w/v and Glucose 2.5% w/v Solution for Infusion BP PA2299/008/003	Sodium chloride, Glucose	Baxter Holding B.V.	Marketed
Sodium Chloride 0.45% w/v and Glucose 5.0% w/v Solution for Infusion BP PA2299/008/001	Sodium chloride, Glucose	Baxter Holding B.V.	Marketed
Sodium Chloride 0.45% w/v Solution for Infusion PA2299/002/002	Sodium chloride	Baxter Holding B.V.	Marketed
Sodium Chloride 0.9% w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) PA2299/008/002	Sodium chloride, Glucose	Baxter Holding B.V.	Marketed
Sodium Chloride 0.9% w/v Intravenous Infusion BP PA2299/002/001	Sodium chloride	Baxter Holding B.V.	Marketed
Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) PA2299/002/003	Sodium chloride	Baxter Holding B.V.	Marketed
Sugammadex 100 mg/ml Solution for Injection PA2299/058/001	Sugammadex sodium	Baxter Holding B.V.	Not marketed
Suprane Inhalation vapour, solution PA2299/023/001	Desflurane	Baxter Holding B.V.	Marketed
TISSEEL Lyo Powder and Solvent for Sealant PA2299/025/002	Human fibrinogen, Aprotinin, Human thrombin, Human factor xiii, Calcium chloride	Baxter Holding B.V.	Marketed
TISSEEL Ready to use Solutions for Sealant PA2299/025/001	Human fibrinogen, Aprotinin, Human factor xiii, Human thrombin, Calcium chloride	Baxter Holding B.V.	Marketed
Tranexamic acid 100 mg/mL solution for injection/infusion PA2299/048/001	TRANEXAMIC ACID PH. EUR.	Baxter Holding B.V.	Not marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion PA2299/043/007	Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine	Baxter Holding B.V.	Marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l, emulsion for infusion PA2299/043/008	Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine	Baxter Holding B.V.	Marketed
Triomel 5g/L nitrogen 990kcal/L with electrolytes, emulsion for infusion PA2299/029/002	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Triomel 7g/L nitrogen 1140kcal/L emulsion for infusion PA2299/029/004	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Triomel 7g/L nitrogen 1140kcal/L with electrolytes emulsion for infusion PA2299/029/003	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Triomel 9g/L nitrogen 1070kcal/L emulsion for infusion PA2299/029/006	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Triomel 9g/L nitrogen 1070kcal/L with electrolytes emulsion for infusion PA2299/029/005	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Triomel Peripheral 4 g/L nitrogen 700 kcal/L with electrolytes emulsion for infusion PA2299/029/001	Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid	Baxter Holding B.V.	Marketed
Uromitexan 100mg/ml Solution for Injection or Infusion PA2299/024/001	Mesna	Baxter Holding B.V.	Marketed
Uromitexan tablets 400 mg PA2299/024/002	Mesna	Baxter Holding B.V.	Marketed
Uromitexan Tablets 600mg PA2299/024/003	Mesna	Baxter Holding B.V.	Marketed
Water for Injections Ph. Eur., viaflo container PA2299/013/001	Water for injection	Baxter Holding B.V.	Marketed

← 1 2

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.